# 16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

> **NCT04150731** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 8 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** 16α-18F-fluor-17β-estradiol

## Key facts

- **NCT ID:** NCT04150731
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2022-10-25
- **Final completion:** 2023-06-28
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150731, "16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04150731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*